Kawakami K, Yamamoto K, Toyoshima S, Osawa T, Irimura T
Division of Chemical Toxicology and Immunochemistry, Faculty of Pharmaceutical Sciences, University of Tokyo.
Jpn J Cancer Res. 1994 Jul;85(7):744-9. doi: 10.1111/j.1349-7006.1994.tb02423.x.
We investigated whether the interaction of peritoneal macrophages with extracellular ligands is mediated by C-type lectins specific for galactose and N-acetylgalactosamine. The carbohydrate-binding domain of mouse galactose/N-acetylgalactosamine-specific lectin was prepared in a recombinant form. The purified recombinant lectins were tested for competitive inhibition against glycoprotein uptake and against tumoricidal effect. Thioglycolate-elicited macrophages internalized galactosylated bovine serum albumin in vitro. The internalization was blocked by recombinant macrophage lectins. Activated macrophages obtained after intraperitoneal injection of a nonspecific immune potentiator, OK432, did not internalize galactosylated bovine serum albumin. These cells elicited a cytotoxic effect against P815 murine mastocytoma cells, and the effect was blocked by recombinant macrophage lectins. These results indicated that galactose/N-acetylgalactosamine-specific C-type lectins expressed on the surface of inflammatory macrophages and on activated tumoricidal macrophages mediate two distinct functions, i.e. glycoprotein uptake and tumoricidal effector mechanisms.
我们研究了腹膜巨噬细胞与细胞外配体的相互作用是否由对半乳糖和N-乙酰半乳糖胺具有特异性的C型凝集素介导。以重组形式制备了小鼠半乳糖/N-乙酰半乳糖胺特异性凝集素的碳水化合物结合结构域。测试了纯化的重组凝集素对糖蛋白摄取和杀肿瘤作用的竞争性抑制。巯基乙酸盐诱导的巨噬细胞在体外内化了半乳糖基化牛血清白蛋白。这种内化被重组巨噬细胞凝集素阻断。腹腔注射非特异性免疫增强剂OK432后获得的活化巨噬细胞没有内化半乳糖基化牛血清白蛋白。这些细胞对P815小鼠肥大细胞瘤细胞产生细胞毒性作用,并且该作用被重组巨噬细胞凝集素阻断。这些结果表明,在炎性巨噬细胞和活化的杀肿瘤巨噬细胞表面表达的半乳糖/N-乙酰半乳糖胺特异性C型凝集素介导两种不同的功能,即糖蛋白摄取和杀肿瘤效应机制。